Insufficient recovery of thymopoiesis predicts for opportunistic infections in allogeneic hematopoietic stem cell transplant recipients

od Wils, Evert-Jan, van der Holt, Bronno, Broers, Annoek E.C., Posthumus-van Sluijs, Sandra J., Gratama, Jan-Willem, Braakman, Eric, Cornelissen, Jan J.
Wydane 2011

ATCT-31 CENTRAL RADIOLOGY REVIEW OF THE BELOB TRIAL: TREATMENT WITH BEVACIZUMAB IN RECURRENT GLIOBLASTOMA IS ASSOCIATED WITH MORE FREQUENT NON-ENHANCING PROGRESSION

od Smits, Marion, Bralten, Linda, Jasperse, Bas, Taal, Walter, Gahrmann, Renske, Walenkamp, Annemiek, Oosterkamp, Rianne, Vernhout, Rene, van der Holt, Bronno, van den Bent, Martin
Wydane w Neuro Oncol (2015)

Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients

od Corthals, Sophie L., Kuiper, Rowan, Johnson, David C., Sonneveld, Pieter, Hajek, Roman, van der Holt, Bronno, Magrangeas, Florence, Goldschmidt, Hartmut, Morgan, Gareth J., Avet-Loiseau, Hervé
Wydane 2011

The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA–identical sibling donors: results of the HOVON‐107 study...

od de Greef, Georgine E., Braakman, Eric, van der Holt, Bronno, Janssen, Jeroen J.W.M., Petersen, Eefke, Vucinic, Vladimir, Thuss, Nicole, Grootes, Meriam, Cornelissen, Jan J.
Wydane w Transfusion (2018)

Nitric oxide production and monoamine oxidase activity in cancer patients during interferon-α therapy

od Fekkes, Durk, Van Gool, Arthur R., Bannink, Marjolein, Sleijfer, Stefan, Kruit, Wim H. J., van der Holt, Bronno, Eggermont, Alexander M. M., Hengeveld, Michiel W., Stoter, Gerrit
Wydane 2008

Tumor Volume as an Alternative Response Measurement for Imatinib Treated GIST Patients

od Schiavon, Gaia, Ruggiero, Alessandro, Schöffski, Patrick, van der Holt, Bronno, Bekers, Dave J., Eechoute, Karel, Vandecaveye, Vincent, Krestin, Gabriel P., Verweij, Jaap, Sleijfer, Stefan, Mathijssen, Ron H. J.
Wydane 2012

Correction: Tumor Volume as an Alternative Response Measurement for Imatinib Treated GIST Patients

od Schiavon, Gaia, Ruggiero, Alessandro, Schöffski, Patrick, van der Holt, Bronno, Bekers, Dave J., Eechoute, Karel, Vandecaveye, Vincent, Krestin, Gabriel P., Verweij, Jaap, Sleijfer, Stefan, Mathijssen, Ron H. J.
Wydane 2013

V-Domain Ig Suppressor of T Cell Activation (VISTA) Expression Is an Independent Prognostic Factor in Multiple Myeloma

od Mutsaers, Pim, Balcioglu, Hayri E., Kuiper, Rowan, Hammerl, Dora, Wijers, Rebecca, van Duin, Mark, van der Holt, Bronno, Broijl, Annemiek, Gregory, Walter, Zweegman, Sonja, Sonneveld, Pieter, Debets, Reno
Wydane w Cancers (Basel) (2021)

Expression profiling of adult acute lymphoblastic leukemia identifies a BCR-ABL1-like subgroup characterized by high non-response and relapse rates

od Boer, Judith M., Koenders, Jasper E., van der Holt, Bronno, Exalto, Carla, Sanders, Mathijs A., Cornelissen, Jan J., Valk, Peter J.M., den Boer, Monique L., Rijneveld, Anita W.
Wydane w Haematologica (2015)

Phase 2 study of carfilzomib, thalidomide, and dexamethasone as induction/consolidation therapy for newly diagnosed multiple myeloma

od Sonneveld, Pieter, Asselbergs, Emilie, Zweegman, Sonja, van der Holt, Bronno, Kersten, Marie Jose, Vellenga, Edo, van Marwijk-Kooy, Marinus, Broyl, Annemiek, de Weerdt, Okke, Lonergan, Sarah, Palumbo, Antonio, Lokhorst, Henk
Wydane w Blood (2015)

CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age

od van den Heuvel-Eibrink, Marry M., van der Holt, Bronno, Burnett, Alan K., Knauf, Wolfgang U., Fey, Martin F., Verhoef, Gregor E. G., Vellenga, Edo, Ossenkoppele, Gert J., Löwenberg, Bob, Sonneveld, Pieter
Wydane 2007

Cancer testis antigens in newly diagnosed and relapse multiple myeloma: prognostic markers and potential targets for immunotherapy

od van Duin, Mark, Broyl, Annemiek, de Knegt, Yvonne, Goldschmidt, Hartmut, Richardson, Paul G., Hop, Wim C. J., van der Holt, Bronno, Joseph-Pietras, Debora, Mulligan, George, Neuwirth, Rachel, Sahota, Surinder S., Sonneveld, Pieter
Wydane 2011

Rapid induction of single donor chimerism after double umbilical cord blood transplantation preceded by reduced intensity conditioning: results of the HOVON 106 phase II study

od Somers, Judith A.E., Braakman, Eric, van der Holt, Bronno, Petersen, Eefke J., Marijt, Erik W.A., Huisman, Cynthia, Sintnicolaas, Kees, Oudshoorn, Machteld, Groenendijk-Sijnke, Marlies E., Brand, Anneke, Cornelissen, Jan J.
Wydane w Haematologica (2014)

4β-hydroxycholesterol as an endogenous CYP3A marker in cancer patients treated with taxanes

od de Graan, Anne-Joy M, Sparreboom, Alex, de Bruijn, Peter, de Jonge, Evert, van der Holt, Bronno, Wiemer, Erik A C, Verweij, Jaap, Mathijssen, Ron H J, van Schaik, Ron H N
Wydane w Br J Clin Pharmacol (2015)

Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8...

od Wester, Ruth, Zweegman, Sonja, van der Holt, Bronno, Kersten, Marie José, Vellenga, Edo, van Marwijk-Kooy, Marinus, Asselbergs, Emelie, de Weerdt, Okke, Minnema, Monique C., Lonergan, Sarah, Palumbo, Antonio, Broijl, Annemiek, Sonneveld, Pieter
Wydane w Hemasphere (2020)

Phase II study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma; the Ca...

od Wester, Ruth, van der Holt, Bronno, Asselbergs, Emelie, Zweegman, Sonja, Kersten, Marie Jose, Vellenga, Edo, van Marwijk Kooy, Marinus, de Weerdt, Okke, Minnema, Monique, Lonergan, Sarah, Palumbo, Antonio, Lokhorst, Henk, Broijl, Annemiek, Sonneveld, Pieter
Wydane w Haematologica (2019)

Evaluation of Patient Enrollment in Oncology Phase I Clinical Trials

od van der Biessen, Diane A.J., Cranendonk, Merlijn A., Schiavon, Gaia, van der Holt, Bronno, Wiemer, Erik A.C., Eskens, Ferry A.L.M., Verweij, Jaap, de Jonge, Maja J.A., Mathijssen, Ron H.J.
Wydane 2013

GE-10 IDENTIFICATION OF PATIENTS WITH RECURRENT GBM THAT BENEFIT FROM BEVACIZUMAB

od Eraslan, Lale Erdem, van den Bent, Martin, Kros, Johan, Oosterkamp, Hendrika, Walenkamp, Annemiek, Beerepoot, Laurens, Hanse, Monique, Buter, J., Honkoop, Aafke, van der Holt, Bronno, Vernhout, R.M., Smitt, Peter Sillevis, Taal, Walter, French, Pim
Wydane 2014

Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab—a report from the BELOB trial

od Gahrmann, Renske, van den Bent, Martin, van der Holt, Bronno, Vernhout, René Michel, Taal, Walter, Vos, Maaike, de Groot, Jan Cees, Beerepoot, Laurens Victor, Buter, Jan, Flach, Zwenneke Hendrieke, Hanse, Monique, Jasperse, Bas, Smits, Marion
Wydane w Neuro Oncol (2017)

Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progre...

od Lokhorst, Henk M., van der Holt, Bronno, Cornelissen, Jan J., Kersten, Marie José, van Oers, Marinus, Raymakers, Reinier, Minnema, Monique C., Zweegman, Sonja, Bos, Gerard, Schaap, Nicolaas, Wittebol, Shulamiet, de Weerdt, Okke, Ammerlaan, Rianne, Sonneveld, Pieter
Wydane w Haematologica (2015)